270.79MMarket Cap
14.56P/E TTM
NAGE Balance Sheet
You can check out the annual or quarterly balance sheets of Niagen Bioscience Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing NAGE stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Niagen Bioscience Inc Have?
In its most recent quarterly, Niagen Bioscience Inc had 66.40M in cash and cash equivalents.
How Much Are Niagen Bioscience Inc's Total Liabilities?
Niagen Bioscience Inc reported 29.87M in total liabilities as of the latest reported quarter, including 19.92M in current liabilities and 9.95M in non-current liabilities.
What Are Niagen Bioscience Inc's Total Assets?
As of the latest reported quarter, Niagen Bioscience Inc's total assets were 106.41M, consisting of 96.81M in current assets and 9.60M in non-current assets.
How Much Shareholders' Equity Does Niagen Bioscience Inc Have?
Niagen Bioscience Inc reported 76.53M in total shareholders' equity as of the latest reported quarter.